(19)
(11) EP 0 690 917 A1

(12)

(43) Date of publication:
10.01.1996 Bulletin 1996/02

(21) Application number: 94911554.0

(22) Date of filing: 11.03.1994
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61P 31/ 12( . )
C12N 5/ 10( . )
A61K 39/ 00( . )
C12R 1/ 92( . )
A61K 39/ 245( . )
C07K 14/ 05( . )
C12P 21/ 02( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1994/002637
(87) International publication number:
WO 1994/020138 (15.09.1994 Gazette 1994/21)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 12.03.1993 US 19930031186

(71) Applicant: THERATECH, INC.
Salt Lake City Utah 84108 (US)

(72) Inventor:
  • PRAKASH, Ramesh
    Salt Lake City, UT 84124 (US)

(74) Representative: Goldin, Douglas Michael 
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) RECOMBINANT EPSTEIN-BARR VIRUS PROTEIN AND ITS USE IN VACCINE